close
close

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

Posted on by Vaseline
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the second quarter ended June 30, 2024.

Second quarter and recent highlights

Related Posts